Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 60687-915

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 60687-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250 mg Divalproex Sodium Er Tablet Blister.jpg (250 mg Divalproex Sodium Er Tablet Blister)

FDA Label Image

250 mg Divalproex Sodium Er Tablets Carton.jpg (250 mg Divalproex Sodium Er Tablets Carton)

250 mg Divalproex Sodium Er Tablets Carton.jpg (250 mg Divalproex Sodium Er Tablets Carton)
This is a description of Divalproex Sodium extended-release tablets, USP, with NDC 60687-904-01 for once-daily dosing. The tablets come in a pack of 100 tablets (10 x 10) and contain valproic acid equivalent to 250 mg. It is prescribed for various conditions and should be stored at 20° to 25°C (68 to 77°F). Each tablet should not be used if the blister is torn or broken. The medication is produced by BlusPoint Laboratories and distributed by American Health Packaging in Columbus, Ohio. It is essential to dispense this medication with a Medication Guide to each patient, and pharmacists should refer to the full prescribing information for proper dosage.*
FDA Label Image

500 mg Divalproex Sodium Er Tablet Blister 100ud.jpg (500 mg Divalproex Sodium Er Tablet Blister 100ud)

FDA Label Image

500 mg Divalproex Sodium Er Tablet Blister 80ud.jpg (500 mg Divalproex Sodium Er Tablet Blister 80ud)

FDA Label Image

500 mg Divalproex Sodium Er Tablets Carton 100ud.jpg (500 mg Divalproex Sodium Er Tablets Carton 100ud)

500 mg Divalproex Sodium Er Tablets Carton 100ud.jpg (500 mg Divalproex Sodium Er Tablets Carton 100ud)
This is a description of a medication package containing Divalproex Sodium Extended-Release Tablets. The tablets are intended for once-daily dosing and come in a pack of 100 tablets (10 x 10). Each film-coated extended-release tablet contains Divalproex sodium equivalent to valproic acid 500 mg. The medication guide should be given to each patient who receives this prescription. The tablets should be stored within a specific temperature range. The package is distributed by American Health Packaging in Columbus, Ohio.*
FDA Label Image

500 mg Divalproex Sodium Er Tablets Carton 80ud.jpg (500 mg Divalproex Sodium Er Tablets Carton 80ud)

500 mg Divalproex Sodium Er Tablets Carton 80ud.jpg (500 mg Divalproex Sodium Er Tablets Carton 80ud)
This text provides information about a medication with the NDC code 60687-915-02, which consists of Divalproex Sodium Extended-Release Tablets, USP. The tablets are meant for once-daily dosing and each contains divalproex sodium equivalent to valproic acid 500 mg. The package contains 80 tablets and is for prescription use only. It instructs to store the tablets at a specific temperature range and warns against using blister packs that are torn or broken. The medication is distributed by American Health Packaging and mentions scanning for the current Medication Guide.*
FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)
This text provides information on the percentage reduction in CPS rate in patients taking Divalproex Sodium Delayed-Release Tablets compared to placebo. It shows the percentage of patients who experienced improvement, no change, and worsening in their condition.*
FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)
This text mentions different percentage reductions in CPS rate, with values ranging from 100% to 2%. It also includes information about high dose and low dose formulations of Divalproex Sodium Delayed-Release Tablets, along with the number of patients involved.*
FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)
This text appears to show numerical values followed by information related to a medication. The medication mentioned is "Divalproex sodium extended-release tablets" and there is a note indicating "p=0.006" for a placebo. The numerical values listed may be related to dosages or concentrations.*
FDA Label Image

Ahp90401

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.